Stress-associated hormone, norepinephrine, increases proliferation and IL-6 levels of human pancreatic duct epithelial cells and can be inhibited by the dietary agent, sulforaphane

International Journal of Oncology

Volumn 33, Issue 2, 2008, Pages 415-419

  Chan, Christina ^a   Lin, Huey Jen ^a,b   Lin, Jiayuh ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

IL 6; Norepinephrine; Sulforaphane

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; NORADRENALIN; RESVERATROL; SULFORAPHANE; VASCULOTROPIN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL STRESS; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; HORMONAL REGULATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN SECRETION;

ANTICARCINOGENIC AGENTS; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-6; NOREPINEPHRINE; PANCREATIC DUCTS; STRESS, PSYCHOLOGICAL; THIOCYANATES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48749130174     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000023     Document Type: Article

References (36)

1. Greenlee R, Murray T, Bolden S and Wingo P: Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
2. Yeo C, Abrams R, Grochow L, Sohn T, Ord S, Hruban R, Zahurak M, Dooley W, Coleman J, Sauter P, Pitt H, Lillemoe K and Cameron J: Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 225: 621-633, 1997.
3. Conlon K, Klimstra D and Brennan M: Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinico-pathologic analysis of 5-year survivors. Ann Surg 223: 273-279, 1996.
4. Lillemoe K: Current management of pancreatic carcinoma. Ann Surg 221: 133-148, 1995.
5. Reiche EM, Nunes SO and Morimoto HK: Stress, depression, the immune system and cancer. Lancet Oncol 5: 617-625, 2004.
6. Kiecolt-Glaser JK and Glaser R: Psychoneuroimmunology and cancer: fact or fiction? Eur J Cancer 35: 1603-1607, 1999.
7. Riley V: Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 189: 465-467, 1975.
8. Saul AN, Oberyszyn TM, Daugherty C, Kusewitt D, Jones S, Jewell S, Malarkey WB, Lehman A, Lemeshow S and Dhabhar FS: Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst 97: 1760-1767, 2005.
9. Padgett DA and Glaser R: How stress influences the immune response. Trends Immunol 4: 444-448, 2003.
10. Glaser R and Kiecolt-Glaser JK: Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 5: 243-251, 2005.
11. Levy SM, Herberman RB, Lippman M, D'Angelo T and Lee J: Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med 17: 67-75, 1991.
12. Stommel M, Given BA and Given CW: Depression and functional status as predictors of death among cancer patients. Cancer 94: 2719-2727, 2002.
13. Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, Onetto N, Ren L, Grechko J, Beltangady M, et al: Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Inst 87: 1316-1322, 1995.
14. Coates A, Porzsolt F and Osoba D: Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33: 1025-1030, 1997.
15. Ganz PA, Lee JJ and Siau J: Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 67: 3131-3135, 1991.
16. Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M and Sood AK: Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 9: 4514-4521, 2003.
17. Sood K, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S and Cole SW: Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 12: 369-375, 2006.
18. Lutgendorf SK, Johnsen EL, Cooper B Anderson B, Sorosky JI, Buller RE and Sood AK: Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 95: 808-815, 2002.
19. Tammela T, Enholm B, Alitalo K and Paavonen K: The biology of vascular endothelial growth factors. Cardiovasc Res 65: 550-563, 2005.
20. Demers M, Couillard J, Belanger S and St-Pierre Y: New roles for matrix metalloproteinases in metastasis. Crit Rev Immunol 25: 493-523, 2005.
21. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and De Pinho RA: The INK4A tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713-723, 1998.
22. Rupp H, Dhalla KS and Dhalla NS: Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow. J Cardiovasc Pharmacol 24 (Suppl. 1): S16-S24, 1994.
23. Schmidt C and Kraft K: Beta-endorphin and catecholamine concentrations during chronic and acute stress in intensive care patients. Eur J Med Res 1: 528-532, 1996.
24. Wu W, Yamaura T, Murakami K, Ogasawara M, Hayashi K, Murata J and Saiki I: Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress. Oncol Res 11: 461-469, 1999.
25. Nilsson M, Armaiz-Pena G, Takahashi R, Lin Y, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf S, Gallick G, Sanguino A, Lopez-Berestein G, Cole S and Sood A: Stress hormones regulate IL-6 expression by human ovarian carcinoma cells through a SRC-dependent mechanism. J Biol Chem 282: 29919-29926, 2007.
26. Olsen G, Mandel J, Gibson R, Wattenberg L and Schuman L: Nutrients and pancreatic cancer: a population-based case-control study. Cancer Causes Control 2: 291-297, 1991.
27. Nkondjock A, Krewski D, Johnson K, Ghadirian P and Group CCRER: Dietary patterns and risk of pancreatic cancer. Int J Cancer 114: 817-823, 2005.
28. Kuroiwa Y, Nishikawa A, Kitamura Y, Kanki K, Ishii Y, Umemura T and Hirose M: Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Lett 241: 275-280, 2006.
29. Pham NA, Jacobberger JW, Schimmer AD, Cao P, Gronda M and Hedley DW: The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol Cancer Ther 3: 1239-1248, 2004.
30. Iglesias M, Plowman G and Woodworth C: Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized and carcinoma-derived cervical cells in vitro. Am J Pathol 146: 944-952, 1995.
31. Chang K, Tsai C, Chiou Y, Chiu C, Jeng K and Huang C: IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol 289: L446-L553, 2005.
32. Wei L, Kuo M, Chen C, Chou C, Lai K, Lee C and Hsieh C: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22: 1517-1527, 2003.
33. Lin M, Lin B, Chang C, Chu C, Su H, Chen S, Jeng Y and Kuo M: IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/ RhoA/ROCK signaling pathway. Int J Cancer 120: 2600-2608, 2007.
34. Jee S, Chu C, Chiu H, Huang Y, Tsai W, Liao Y and Kuo M: Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways. J Invest Dermatol 123: 1169-1175, 2004.
35. Nilsson M, Langley R and Fidler I: Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 65: 10794-10800, 2005.
36. Aggarwal B and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421, 2006.